DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Trauner M, Gulamhusein A, Hameed B. , et al.
The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC.
Hepatology 2019 , in press
Access:
We do not assume any responsibility for the contents of the web pages of other providers.